Anticipated Launch of Generic Celebrex

It is anticipated the generic launch of Celebrex (celecoxib) is imminent, following approval by the U.S. Food and Drug Administration (FDA) earlier this year. Initially, the generic celecoxib will have 180-day marketing exclusivity by a limited number of manufacturers. During this exclusivity period, pricing may not vary significantly from the cost of the brand Celebrex. Once the exclusivity period has expired, it is anticipated that other manufacturers will enter the market, which will have a favorable impact on cost.

Generic prescription drugs approved by the FDA have the same quality and strength as brand-name drugs. Generic drug manufacturing and packaging sites must pass the same quality standards as those of brand-name drugs. Celebrex (celecoxib) is a Non-Steriodal Anti-Inflammatory Drug (NSAID) used to treat pain or inflammation.

Carlisle Medical encourages generic prescriptions and will notify prescribing physicians of the generic celecoxib as part of our pharmacy management service, once it has been introduced. If you have any questions on this, please do not hesitate to contact us at pharmacy@carlislemedical.com or 800-553-1783.